DYN
Price:
$33.03
Market Cap:
$3.32B
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..[Read more]
Industry
Biotechnology
IPO Date
2020-09-17
Stock Exchange
NASDAQ
Ticker
DYN
According to Dyne Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.73B. This represents a change of 85.58% compared to the average of 1.47B of the last 4 quarters.
The mean historical Enterprise Value of Dyne Therapeutics, Inc. over the last ten years is 4.32B. The current 2.73B Enterprise Value has changed 6.23% with respect to the historical average. Over the past ten years (40 quarters), DYN's Enterprise Value was at its highest in in the June 2017 quarter at 12.74B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
4.32B
Median
885.28M
Minimum
1.46M
Maximum
11.94B
Discovering the peaks and valleys of Dyne Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.77%
Maximum Annual Enterprise Value = 11.94B
Minimum Annual Increase = -99.86%
Minimum Annual Enterprise Value = 1.46M
Year | Enterprise Value | Change |
---|---|---|
2023 | 699.58M | 51.84% |
2022 | 460.74M | 5.44% |
2021 | 436.95M | 29.77% |
2020 | 1.46M | -99.86% |
2019 | 1.07B | 342.52% |
2018 | 242.02M | -97.97% |
2017 | 11.94B | 16.08% |
2016 | 10.29B | 5.27% |
2015 | 9.77B | 18.48% |
2014 | 8.25B | 133.04% |
The current Enterprise Value of Dyne Therapeutics, Inc. (DYN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
532.43M
5-year avg
533.94M
10-year avg
4.32B
Dyne Therapeutics, Inc.’s Enterprise Value is greater than Stoke Therapeutics, Inc. (586.20M), greater than Pliant Therapeutics, Inc. (762.35M), less than Cytokinetics, Incorporated (6.96B), less than Revolution Medicines, Inc. (6.80B), greater than Edgewise Therapeutics, Inc. (1.60B), greater than Cullinan Oncology, Inc. (930.13M), greater than Mineralys Therapeutics, Inc. (490.57M), greater than DICE Therapeutics, Inc. (2.21B), less than Karuna Therapeutics, Inc. (12.43B), less than Gracell Biotechnologies Inc. (5.45B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Design Therapeutics, Inc. (221.42M), greater than Erasca, Inc. (689.13M),
Company | Enterprise Value | Market cap |
---|---|---|
586.20M | $773.92M | |
762.35M | $782.51M | |
6.96B | $6.36B | |
6.80B | $6.99B | |
1.60B | $1.64B | |
930.13M | $1.04B | |
490.57M | $558.43M | |
2.21B | $2.27B | |
12.43B | $12.60B | |
5.45B | $989.87M | |
138.26M | $181.50M | |
284.72M | $349.21M | |
221.42M | $264.42M | |
689.13M | $807.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dyne Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dyne Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Dyne Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Dyne Therapeutics, Inc. (DYN)?
What is the 3-year average Enterprise Value for Dyne Therapeutics, Inc. (DYN)?
What is the 5-year average Enterprise Value for Dyne Therapeutics, Inc. (DYN)?
How does the current Enterprise Value for Dyne Therapeutics, Inc. (DYN) compare to its historical average?